Ms. Yoori Lee currently serves as Cofounder and President of Trio Health Advisory Group, Inc. Trio Health’s mission is to improve the quality of care in patient outcomes through coordinating the efforts of all patient care stakeholders. Its first-of-its-kind technology platform tracks patients throughout their journey, giving pharmaceutical/biotechnology companies, specialty pharmacies, and physicians real-time access to information that simply does not exist anywhere else. Trio Health focuses on specialty disease states, such as hepatitis C, HIV, oncology, and cystic fibrosis, among others, and examines how each stakeholder impacts the performance of the patient. Trio Health has published extensively on real-world patients; publication topics have included access to care, comparative effectiveness, physician and pharmacy performance, safety and tolerability, affordability between treatment regimens, and various other cohort analyses.
Prior to Trio Health, Ms. Lee spent over 15 years at Leerink Partners LLC, a leading healthcare investment bank, where she was Managing Director and Director of MEDACorp Services. Additionally, she helped found the MEDACorp network, a cadre of experts including more than 35,000 healthcare professionals in diverse areas of practice, such as clinical medicine, biomedical research, regulatory affairs, public policy, healthcare administration, and healthcare information technology.
Ms. Lee has delivered value-driving business and decision support strategies to companies ranging from emerging growth to the world’s largest pharmaceutical companies. With more than 20 years of consulting experience, she has unique experience in developing scientific, clinical, regulatory, and commercial solutions for clients by bringing together a best-in-class network of “in-the-trenches” consultants. Through these close relationships and collaborations, she has been instrumental in developing intricate consulting strategies, amassing numerous advisory boards, and aligning strategic objectives predicated on thorough assessments of competitive landscapes, as well as developing and managing pre- and postmarketing programs.